Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000174317 | SCV000225598 | benign | not specified | 2015-04-08 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000174317 | SCV000246865 | likely benign | not specified | 2015-05-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002313031 | SCV000849061 | benign | Inborn genetic diseases | 2017-02-15 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001079336 | SCV001005987 | benign | Intellectual disability, CASK-related, X-linked | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000865081 | SCV001156008 | uncertain significance | not provided | 2016-06-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000865081 | SCV001941550 | benign | not provided | 2019-01-29 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003965254 | SCV004781604 | likely benign | CASK-related condition | 2019-09-11 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |